Immune Evasion Strategies of Glioblastoma


Glioblastoma (GBM) is the most devastating brain tumor, with associated poor prognosis. Despite advances in surgery and chemoradiation, the survival of afflicted patients has not improved significantly in the past three decades. Immunotherapy has been heralded as a promising approach in treatment of various cancers; however, the immune privileged… (More)
DOI: 10.3389/fsurg.2016.00011


Cite this paper

@inproceedings{Razavi2016ImmuneES, title={Immune Evasion Strategies of Glioblastoma}, author={S. Farhad Razavi and Karen E. Lee and Benjamin E. Jin and Parvir S. Aujla and Sharareh Gholamin and Gordon Li}, booktitle={Front. Surg.}, year={2016} }